cirrhosis

Documents about cirrhosis

• RTX001 Autologous Engineered Macrophages for Liver Cirrhosis#834070ClinicalTrials.gov
• Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis#968719ClinicalTrials.gov
• Zinc Supplementation in Alcoholic Cirrhosis#906874ClinicalTrials.gov
• Cirrhosis Medical Home#454161ClinicalTrials.gov
• Pentoxifylline for Primary Biliary Cirrhosis#878151ClinicalTrials.gov
• Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound#898836ClinicalTrials.gov
• Rifaximin Predicts the Complications of Decompensated Cirrhosis#848059ClinicalTrials.gov
• Prospective Cohort Study of Disease and Outcomes in Cirrhosis#850460ClinicalTrials.gov
• Terlipressin in Septic Shock in Cirrhosis#847936ClinicalTrials.gov
• A Study of IDN-6556 in Subjects With Liver Cirrhosis#857128ClinicalTrials.gov
• SII in AKI With Cirrhosis#826614ClinicalTrials.gov
• Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis#311013ClinicalTrials.gov
• Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis#851461ClinicalTrials.gov
• Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis#844839ClinicalTrials.gov
• DOAC in Patients with Child a or B Liver Cirrhosis#831729ClinicalTrials.gov
• Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis#864938ClinicalTrials.gov
• Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis#880994ClinicalTrials.gov
• Cirrhosis Registry of Hospitalized Patients#902804ClinicalTrials.gov
• Nutritional Assessment in Individuals with Liver Cirrhosis#394648ClinicalTrials.gov
• Study of microRNAs in a Decompensated Cirrhosis#311159ClinicalTrials.gov
• Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis#429655ClinicalTrials.gov
• Assessment Of Lipid Profile In Cirrhotic Patients#800950ClinicalTrials.gov
• Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis#858307ClinicalTrials.gov
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension#851876ClinicalTrials.gov
• Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial#863545ClinicalTrials.gov
• Chemotherapy and Liver Cirrhosis in Frequently-associated Cancers#884181ClinicalTrials.gov
• Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension#442063ClinicalTrials.gov
• Effect of Coconut Milk Supplementation to Improve Nutritional Status in Cirrhosis Patient#804281ClinicalTrials.gov
• Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis#851160ClinicalTrials.gov
• Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites#901503ClinicalTrials.gov
• Vibration Training Approach in Liver Cirrhosis#812355ClinicalTrials.gov
• An Follow-Up Study of Liver Cirrhosis#913653ClinicalTrials.gov
• Diagnosis of Variceal Bleeding and Its Control in Cirrhosis#968188ClinicalTrials.gov
• Composition for Treating Cirrhosis and Liver Cancer (SB-1121)#834367ClinicalTrials.gov
• In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis#979763ClinicalTrials.gov
• Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis#160210ClinicalTrials.gov
• Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China#249622ClinicalTrials.gov
• Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes#414469ClinicalTrials.gov
• Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis#424259ClinicalTrials.gov
• Portal Vein Thrombosis in Cirrhosis#833670ClinicalTrials.gov
• The Cirrhosis Outpatient Optimization, Readmission & Safety Study#856994ClinicalTrials.gov
• Thrombin Generation Test in Patient With Liver Cirrhosis#891960ClinicalTrials.gov
• Myocardial Fibrosis and Inflammation in Liver Cirrhosis#916399ClinicalTrials.gov
• Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis#833612ClinicalTrials.gov
• Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis#882642ClinicalTrials.gov
• The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis Patients#891106ClinicalTrials.gov
• A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis#899929ClinicalTrials.gov
• Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis#901003ClinicalTrials.gov
• Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma#855555ClinicalTrials.gov
• To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis#884600ClinicalTrials.gov